Sernova Biotherapeutics Inc (TSX:SVA)
Canada
· Delayed Price · Currency is CAD 0.160
-0.005 (-3.03%)
At close: Mar 6, 2026
Sernova Biotherapeutics Employees
Sernova Biotherapeutics had 8 employees as of October 31, 2025. The number of employees decreased by 9 or -52.94% compared to the previous year.
Employees
8
Change (1Y)
-9
Growth (1Y)
-52.94%
Revenue / Employee
n/a
Profits / Employee
-1.97M CAD
Market Cap
54.63M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Oct 31, 2025 | 8 | -9 | -52.94% |
| Oct 31, 2024 | 17 | - | - |
Sernova Biotherapeutics News
- 3 days ago - Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to Shareholder Approval - Newsfile Corp
- 15 days ago - Sernova to amend warrants, extend expiry, and cut exercise price - Seeking Alpha
- 15 days ago - Sernova Biotherapeutics Announces Warrant Amendments - Newsfile Corp
- 5 months ago - Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang - Newsfile Corp
- 5 months ago - Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors - TheNewswire
- 6 months ago - Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference - TheNewswire
- 8 months ago - Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes - GlobeNewsWire
- 9 months ago - Sernova Appoints Jonathan Rigby as Interim Chair - GlobeNewsWire